Company
Collaborations Pharmaceuticals (United States)
Raleigh, United States · collaborationspharma.com
- Citations, last 5 years
- 1 061
- Works, last 5 years
- 113
- h-index
- 61
- Scientists listed
- 9
- Grants since 2016
- 38
Grants received
2025–2026 · contract · N44
Discovery and Development of Oral Small-molecule Direct-acting Antivirals
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2024–2026 · grant · SB1
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2024–2026 · grant · SB1
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Preclinical development of a Nipah Virus inhibitor
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2022–2024 · research · R43
New therapeutic approaches to identifying molecules for opioid abuse treatment
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2021–2023 · research · R43
Machine learning approaches to predict Acetylcholinesterase inhibition
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2021–2026 · research · R44
Machine learning approaches to predict Acetylcholinesterase inhibition and model applications
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2021–2027 · research · R44
Machine learning approaches to predict Acetylcholinesterase inhibition and model applications
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2020–2022 · research · R43
MegaTox for analyzing and visualizing data across different screening systems
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2021 · research · R43
MegaPredict for predicting natural product uses and their drug interactions
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2022 · research · R41
MegaTrans – human transporter machine learning models
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2025 · research · R44
MegaTox for analyzing and visualizing data across different screening systems
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2021 · research · R43
MegaPredict for predicting natural product uses and their drug interactions
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2025 · research · R42
MegaTrans – human transporter machine learning models
Nathan J Cherrington · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2024 · research · R42
MegaTrans – human transporter machine learning models
Nathan J Cherrington · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019 · research · R43
Enzyme Replacement Therapy For Infantile Onset Neuronal Ceroid Lipofuscinoses
Jonathan D Cooper · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2024 · research · R44
MegaTox for analyzing and visualizing data across different screening systems
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2019–2022 · research · R43
MegaTox for analyzing and visualizing data across different screening systems
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2025 · research · R44
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2024 · research · R44
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Enzyme Replacement Therapy For Infantile Onset Neuronal Ceroid Lipofuscinoses
Jonathan D Cooper · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Enzyme Replacement Therapy For Infantile Onset Neuronal Ceroid Lipofuscinoses
Jonathan D Cooper · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2018–2019 · research · R41
Structure-guided optimization of an in vivo active small molecule antitubercular targeting KasA
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017 · research · R43
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2024 · research · R44
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2021 · cooperative agreement · UH2
Repurposing pyronaridine as a treatment for Chagas disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2020 · research · R01
New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2020 · research · R01
New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2019 · cooperative agreement · UH2
Repurposing pyronaridine as a treatment for Chagas disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2023 · research · R44
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2021 · research · R01
New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2021 · cooperative agreement · UH2
Repurposing pyronaridine as a treatment for Chagas disease
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Centralized assay datasets for modelling support of small drug discovery organizations
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2016–2019 · research · R21
Repurposing pyronaridine as a treatment for the Ebola virus
Robert A Davey · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2016–2018 · research · R41
Optimization of small molecule triazine antituberculars for in vivo efficacy
Sean Ekins · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health
2016–2018 · research · R21
Repurposing pyronaridine as a treatment for the Ebola virus
Robert A Davey · Collaborations Pharmaceuticals (United States) · funded by National Institutes of Health